The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
- 25 October 2017
- journal article
- review article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 41 (12) , 1986-1999
Abstract
Corticotropin releasing factor (CRF) is a neuropeptide that plays a key role in behavioral and physiological responses to stress. A large body of animal literature implicates CRF acting at type 1 CRF receptors (CRFR1) in consumption by alcohol‐dependent subjects, stress‐induced reinstatement of alcohol seeking, and possibly binge alcohol consumption. These studies have encouraged recent pilot studies of CRFR1 antagonists in humans with alcohol use disorder (AUD). It was a great disappointment to many in the field that these studies failed to show an effect of these compounds on stress‐induced alcohol craving. Here, we examine these studies to explore potential limitations and discuss preclinical and human literature to ask whether CRFR1 is still a valid drug target to pursue for the treatment of AUD.Keywords
Funding Information
- National Institutes of Health (AA013588, AA019455, AA026075)
- National Science Foundation (DGE‐1110007)
This publication has 191 references indexed in Scilit:
- Varenicline decreases alcohol consumption in heavy-drinking smokersPsychopharmacology, 2012
- Effects of Adrenal Sensitivity, Stress- and Cue-Induced Craving, and Anxiety on Subsequent Alcohol Relapse and Treatment OutcomesArchives of General Psychiatry, 2011
- Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individualsPsychopharmacology, 2011
- Translational and reverse translational research on the role of stress in drug craving and relapsePsychopharmacology, 2011
- Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429Psychopharmacology, 2011
- Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response controlPsychopharmacology, 2011
- Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in ratsPsychopharmacology, 2011
- A preliminary investigation of varenicline for heavy drinking smokersPsychopharmacology, 2011
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findingsBiochemical Pharmacology, 2008